pISSN 1226-6051
eISSN 2508-786X

Table. 3.

Table. 3.

TFTs monitoring by thyroid-related adverse events

Occurrence of Thyroid-related adverse events, n(%) Total (n=215) P-value

Yes (n=43) No (n=172)
Baseline TFTs, n(%) >.999
Yes 9 (20.9) 38 (22.1) 47 (21.9)
No 34 (79.1) 134 (77.9) 168 (78.1)
During Therapy TFTs, n(%) <0.001*
Yes 33 (76.7) 32 (18.6) 65 (30.2)
No 10 (23.3) 140 (81.4) 150 (69.8)
After Therapy TFTs, n(%) <0.001*
Yes 23 (53.5) 24 (14.0) 47 (21.9)
No 20 (46.5) 148 (86.0) 168 (78.1)

TFTs, thyroid function tests

*indicates P<0.05

Korean J Clin Pharm 2021;31:188-97 https://doi.org/10.24304/kjcp.2021.31.3.188
© 2021 Korean J Clin Pharm